Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Organon ( (OGN) ).
On October 26, 2025, Kevin Ali resigned as CEO and board member of Organon due to an investigation into the company’s wholesaler sales practices. The Audit Committee’s investigation revealed improper sales practices involving Nexplanon, which allowed the company to meet revenue expectations during certain periods. As a result, Organon appointed Joseph Morrissey as Interim CEO and Carrie S. Cox as Executive Chair. The company is taking steps to improve financial controls and address material weaknesses, while initiating a search for a permanent CEO.
The most recent analyst rating on (OGN) stock is a Sell with a $14.00 price target. To see the full list of analyst forecasts on Organon stock, see the OGN Stock Forecast page.
Spark’s Take on OGN Stock
According to Spark, TipRanks’ AI Analyst, OGN is a Neutral.
Organon’s overall stock score is primarily impacted by its financial challenges, including declining revenue and high leverage. The company’s attractive valuation and strategic debt repayment provide some positive aspects. However, mixed technical indicators and operational challenges highlighted in the earnings call contribute to a moderate overall score.
To see Spark’s full report on OGN stock, click here.
More about Organon
Organon is a global healthcare company headquartered in Jersey City, New Jersey, with a mission to deliver impactful medicines and solutions for a healthier every day. The company offers a portfolio of over 70 products across Women’s Health and General Medicines, including biosimilars, focusing on health needs that uniquely, disproportionately, or differently affect women, while expanding access to essential treatments in over 140 markets.
Average Trading Volume: 4,034,910
Technical Sentiment Signal: Sell
Current Market Cap: $2.38B
For an in-depth examination of OGN stock, go to TipRanks’ Overview page.